This cohort study examines rates of chronic kidney disease in relation to use of lithium, anticonvulsants, and other drugs for treatment of bipolar disorder.
Hampton et al estimate the numbers and rates of adverse drug event emergency department visits involving psychiatric medications among US adults between 2009 and 2011. Medical records from national probability samples were reviewed and analyzed. Exposures were antidepressants, antipsychotics, lithium salts, sedatives and anxiolytics, and stimulants.
Khan et al assessed mortality risk among adult patients with a diagnosis of schizophrenia, depression, bipolar disorder, anxiety disorder, or attention-deficit/hyperactivity disorder participating in clinical trials and evaluated if psychopharmacological agents worsen this risk.